Literature DB >> 7494666

Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes.

H Zola1, M Fusco, P J Macardle, L Flego, D Roberton.   

Abstract

The expression of receptors for several cytokines (IL 2, IL-4, IL-6, IL-7, tumor necrosis factor, and interferon-gamma) was examined in human cord blood cells in comparison with adult blood cells. A previously described high sensitivity immunofluorescence procedure was used to render the low levels of receptor measurable. Cord blood lymphocytes expressed measurable levels of most cytokine receptors, but expression tended to be lower than in adult blood cells. Examination of different lymphocyte subpopulations revealed a complex pattern with some cell types expressing particular receptors equivalent to adult levels. Cord and adult blood monocytes expressed similar cytokine receptor profiles. Receptor expression in cord lymphocytes could be regulated by activation. The results provide indications as to the relative activities of different cytokines in the development of the immune system in the neonate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494666     DOI: 10.1203/00006450-199509000-00021

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

1.  Development of interleukin-12-producing capacity throughout childhood.

Authors:  John W Upham; Peter T Lee; Barbara J Holt; Tricia Heaton; Susan L Prescott; Mary J Sharp; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 2.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

3.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 4.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

5.  Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population.

Authors:  Ilka Engelmann; Ulrike Moeller; Andrea Santamaria; Peter G Kremsner; Adrian J F Luty
Journal:  Immunology       Date:  2006-09-20       Impact factor: 7.397

6.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

7.  Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery.

Authors:  A Kotiranta-Ainamo; M Apajasalo; M Pohjavuori; N Rautonen; J Rautonen
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 8.  The role of B cells and accessory cells in the neonatal response to TI-2 antigens.

Authors:  Cheri D Landers; R Lakshman Chelvarajan; Subbarao Bondada
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults.

Authors:  Katherine A Barsness; Denis D Bensard; David A Partrick; Casey M Calkins; Richard J Hendrickson; Anirban Banerjee; Robert C McIntyre
Journal:  Pediatr Surg Int       Date:  2004-04-21       Impact factor: 1.827

10.  Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA.

Authors:  L Tasker; S Marshall-Clarke
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.